GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InteliCare Holdings Ltd (ASX:ICR) » Definitions » Research & Development

InteliCare Holdings (ASX:ICR) Research & Development : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is InteliCare Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. InteliCare Holdings's Research & Development for the six months ended in Dec. 2023 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.


InteliCare Holdings Research & Development Historical Data

The historical data trend for InteliCare Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InteliCare Holdings Research & Development Chart

InteliCare Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Research & Development
- - - -

InteliCare Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

InteliCare Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InteliCare Holdings  (ASX:ICR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


InteliCare Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of InteliCare Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


InteliCare Holdings (ASX:ICR) Business Description

Traded in Other Exchanges
N/A
Address
299 Vincent Street, Level 1, Leederville, Perth, WA, AUS, 6007
InteliCare Holdings Ltd is an Australian firm engaged in healthcare solutions through hardware, software service packaging which supports aging or disabled persons. Its platform provides families and caregivers with a real-time view of the well-being of people in an independent living environment. Business software uses discreet sensors that are placed around the home, in doorways and on key appliances, designed to gather information on movement, activity levels, temperature and more, to relay information about behaviour such as sleeping patterns, social outings, meal preparation, any potential health issues etc. The product portfolio includes InteliCare Hub, Smart sensors, Downloadable Applications, and Optional Duress Pendants. Substantial revenue comes from hardware sales.

InteliCare Holdings (ASX:ICR) Headlines

No Headlines